Lorna M. Lopez

29.7k total citations
34 papers, 882 citations indexed

About

Lorna M. Lopez is a scholar working on Genetics, Molecular Biology and Physiology. According to data from OpenAlex, Lorna M. Lopez has authored 34 papers receiving a total of 882 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 10 papers in Molecular Biology and 8 papers in Physiology. Recurrent topics in Lorna M. Lopez's work include Genetic Associations and Epidemiology (8 papers), Alzheimer's disease research and treatments (5 papers) and Genomic variations and chromosomal abnormalities (5 papers). Lorna M. Lopez is often cited by papers focused on Genetic Associations and Epidemiology (8 papers), Alzheimer's disease research and treatments (5 papers) and Genomic variations and chromosomal abnormalities (5 papers). Lorna M. Lopez collaborates with scholars based in Ireland, United Kingdom and United States. Lorna M. Lopez's co-authors include Melanie Föcking, Patrick Dicker, David Cotter, Jane A. English, Kieran Wynne, Gerard Cagney, Gregory M. Landes, P. A. Locke, Terry J. Lerner and Richard P. Harvey and has published in prestigious journals such as Nature, Nature Communications and Blood.

In The Last Decade

Lorna M. Lopez

29 papers receiving 868 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lorna M. Lopez Ireland 12 343 277 182 111 94 34 882
John D. H. Stead Canada 19 244 0.7× 455 1.6× 93 0.5× 187 1.7× 73 0.8× 25 1.3k
Gabriel Oh Canada 13 366 1.1× 694 2.5× 139 0.8× 39 0.4× 142 1.5× 18 1.1k
Simone de Jong United Kingdom 19 406 1.2× 680 2.5× 70 0.4× 186 1.7× 130 1.4× 39 1.2k
Ciara Fahey Ireland 19 286 0.8× 572 2.1× 78 0.4× 95 0.9× 55 0.6× 25 1.2k
Lin Xie United States 21 330 1.0× 809 2.9× 135 0.7× 134 1.2× 98 1.0× 42 1.3k
Sun-Chong Wang Taiwan 9 652 1.9× 1.0k 3.7× 248 1.4× 67 0.6× 80 0.9× 12 1.4k
Cyril Peter United States 12 256 0.7× 470 1.7× 77 0.4× 45 0.4× 52 0.6× 16 713
Thomas Tang Canada 6 578 1.7× 897 3.2× 183 1.0× 58 0.5× 59 0.6× 6 1.2k
Julien Bryois United States 17 735 2.1× 797 2.9× 64 0.4× 100 0.9× 134 1.4× 27 1.7k
Christina M. Hultman Sweden 16 967 2.8× 628 2.3× 65 0.4× 133 1.2× 50 0.5× 26 1.7k

Countries citing papers authored by Lorna M. Lopez

Since Specialization
Citations

This map shows the geographic impact of Lorna M. Lopez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorna M. Lopez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorna M. Lopez more than expected).

Fields of papers citing papers by Lorna M. Lopez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorna M. Lopez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorna M. Lopez. The network helps show where Lorna M. Lopez may publish in the future.

Co-authorship network of co-authors of Lorna M. Lopez

This figure shows the co-authorship network connecting the top 25 collaborators of Lorna M. Lopez. A scholar is included among the top collaborators of Lorna M. Lopez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorna M. Lopez. Lorna M. Lopez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Timofeeva, Maria, Cathy Wyse, Jos van Geffen, et al.. (2025). Genome-wide gene-environment interaction study uncovers 162 vitamin D status variants using a precise ambient UVB measure. Nature Communications. 16(1). 10774–10774.
2.
Patel, Maulikkumar, Cyril Pottier, Kang-Hsien Fan, et al.. (2025). Whole-genome sequencing reveals the impact of lipid pathway and APOE genotype on brain amyloidosis. Human Molecular Genetics. 34(8). 739–748. 1 indexed citations
4.
Wyse, Cathy, et al.. (2024). Circadian Variation in the Response to Vaccination: A Systematic Review and Evidence Appraisal. Journal of Biological Rhythms. 39(3). 219–236. 2 indexed citations
5.
Fahey, Laura & Lorna M. Lopez. (2024). Shared Genetic Links Between Sleep, Neurodevelopmental and Neuropsychiatric Conditions: A Genome‐Wide and Pathway‐Based Polygenic Score Analysis. Genes Brain & Behavior. 23(6). e70011–e70011. 2 indexed citations
6.
Heron, Elizabeth A., et al.. (2024). Polygenic scores stratify neurodevelopmental copy number variant carrier cognitive outcomes in the UK Biobank. npj Genomic Medicine. 9(1). 43–43.
7.
Cronjé, Héléne T., Manja Koch, Annette L. Fitzpatrick, et al.. (2024). Circulating sphingolipids in relation to cognitive decline and incident dementia: The Cardiovascular Health Study. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 16(3). e12623–e12623. 1 indexed citations
8.
Barzilay, Joshua I., Petra Bůžková, W.T. Longstreth, et al.. (2024). The Association of Impaired Vibration Sensation in the Lower Limb with Tests of Cognition in Older People: The Cardiovascular Health Study. Dementia and Geriatric Cognitive Disorders. 54(3). 145–152.
9.
Wyse, Cathy, et al.. (2022). Susceptibility to the common cold virus is associated with day length. iScience. 25(8). 104789–104789. 1 indexed citations
10.
McCarthy, Ellen P., et al.. (2022). Brief Report: Evaluating the Diagnostic Yield of Commercial Gene Panels in Autism. Journal of Autism and Developmental Disorders. 53(1). 484–488. 6 indexed citations
11.
Zhang, Song, et al.. (2021). Prognostic accuracy for predicting ordinal competing risk outcomes using ROC surfaces. Lifetime Data Analysis. 28(1). 1–22. 1 indexed citations
12.
Gallagher, Louise, et al.. (2020). Autism spectrum disorder genomics: The progress and potential of genomic technologies. Genomics. 112(6). 5136–5142. 9 indexed citations
13.
English, Jane A., Lorna M. Lopez, Aoife O’Gorman, et al.. (2017). Blood-Based Protein Changes in Childhood Are Associated With Increased Risk for Later Psychotic Disorder: Evidence From a Nested Case–Control Study of the ALSPAC Longitudinal Birth Cohort. Schizophrenia Bulletin. 44(2). 297–306. 46 indexed citations
14.
Föcking, Melanie, Lorna M. Lopez, Jane A. English, et al.. (2014). Proteomic and genomic evidence implicates the postsynaptic density in schizophrenia. Molecular Psychiatry. 20(4). 424–432. 121 indexed citations
15.
Gomez, Lissette, K. Wigg, Lorna M. Lopez, et al.. (2014). Association of the KCNJ5 gene with Tourette Syndrome and Attention‐Deficit/Hyperactivity Disorder. Genes Brain & Behavior. 13(6). 535–542. 10 indexed citations
16.
Deary, Ian J., Jian Yang, Gail Davies, et al.. (2012). Genetic contributions to stability and change in intelligence from childhood to old age. Nature. 482(7384). 212–215. 169 indexed citations
17.
Lopez, Lorna M., Mark E. Bastin, Susana Muñoz Maniega, et al.. (2012). A genome-wide search for genetic influences and biological pathways related to the brain's white matter integrity. Neurobiology of Aging. 33(8). 1847.e1–1847.e14. 35 indexed citations
18.
Rosenthal, Samantha L., Xingbin Wang, F. Yesim Demirci, et al.. (2012). Beta-amyloid toxicity modifier genes and the risk of Alzheimer's disease.. PubMed. 1(2). 191–8. 27 indexed citations
19.
Morange, Pierre‐Emmanuel, Tiphaine Oudot‐Mellakh, William Cohen, et al.. (2011). KNG1 Ile581Thr and susceptibility to venous thrombosis. Blood. 117(13). 3692–3694. 40 indexed citations
20.
Lopez, Lorna M. & James T. Becker. (2002). tratamiento de la enfermedad de Alzheimer. Revista de Neurología. 35(9). 850–850. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026